Carnegie Mellon Exosome Engineering Tech Licensed to Coya Therapeutics - News

CMU has licensed a proprietary platform for bioengineering exosomes for drug delivery to Coya Therapeutics, Inc.

Related Keywords

Krzysztof Matyjaszewski ,Sushil Lathwal ,Howard Berman ,Adrian Hepner ,Carnegie Mellon Exosome ,Phil Campbell ,Subhar Das ,Coya Therapeutics Inc ,Carnegie Mellon University ,Mellon College Of Science Department Chemistry ,College Of Engineering Department Biomedical ,Mellon Exosome Engineering Tech Licensed ,Mellon University ,Coya Therapeutics ,Mellon College ,Biomedical Engineering ,